Chemical inhibitors of 9030612M13Rik can be characterized by their specific inhibition mechanisms affecting the protein's activity within cellular signaling pathways. Staurosporine operates by targeting the ATP-binding site that is essential for kinase activity associated with 9030612M13Rik, leading to a direct decrease in its kinase function. Similarly, Bisindolylmaleimide I suppresses Protein Kinase C, which plays a crucial role in phosphorylation processes that can affect the phosphorylation state and subsequent activation of 9030612M13Rik. LY294002 and Wortmannin serve as inhibitors of phosphoinositide 3-kinases, which are upstream regulators of the Akt signaling pathway. The inhibition of this pathway by these chemicals can result in a reduction of 9030612M13Rik activation due to decreased upstream signaling. PD98059 and U0126 are selective inhibitors of MEK1/2 enzymes within the MAPK/ERK pathway, and their inhibitory action can attenuate the activation of 9030612M13Rik by impeding the necessary upstream signals that would otherwise contribute to its functional state.
Further, SB203580's inhibition of p38 MAP kinase and SP600125's inhibition of JNK both can lead to a reduction in the functional activity of 9030612M13Rik by interfering with downstream signaling processes and preventing activation. Rapamycin, targeting the mTOR pathway, disrupts a key regulatory pathway which can have a consequential effect on the activity of 9030612M13Rik. The Src family kinases, known to be involved in phosphorylation that may activate 9030612M13Rik, can be inhibited by PP2, thereby leading to a decrease in the protein's activity. Additionally, Dasatinib and Imatinib, by inhibiting broad-spectrum tyrosine kinases and Bcr-Abl tyrosine kinase respectively, can obstruct the phosphorylation processes that are essential for the activation and function of 9030612M13Rik, leading to its inhibition. These chemicals serve as functional inhibitors that can alter the activity of 9030612M13Rik by directly blocking the action of kinases or impeding pathways that are crucial for the protein's activation and function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine inhibits 9030612M13Rik by blocking the ATP-binding site essential for its kinase activity, leading to a decrease in the protein's kinase function. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Bisindolylmaleimide I inhibits Protein Kinase C which is essential for phosphorylation processes; inhibition of this enzyme can lead to a decrease in phosphorylation and activation of 9030612M13Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits phosphoinositide 3-kinases which are upstream of Akt signaling pathway; inhibition of this pathway can decrease the activation and function of 9030612M13Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin inhibits phosphoinositide 3-kinase activity, which is crucial for the activation of Akt pathway; this can lead to a decline in the functional activity of 9030612M13Rik by inhibiting the necessary upstream signals. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 selectively inhibits MEK1/2 within the MAPK/ERK pathway; by inhibiting upstream signals, this compound can decrease the activation of 9030612M13Rik. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 acts as an inhibitor of MEK1/2, which are upstream kinases in the MAPK/ERK pathway; this can lead to the inhibition of 9030612M13Rik by preventing its activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 inhibits p38 MAP kinase, which can lead to a reduction in the functional activity of 9030612M13Rik by hindering the downstream signaling processes that the protein may be involved in. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which can lead to the inhibition of 9030612M13Rik by preventing its activation within the JNK signaling pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which can lead to the functional inhibition of 9030612M13Rik by disrupting the pathway that may regulate the protein's activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
PP2 inhibits Src family kinases which can lead to a decrease in the phosphorylation and subsequent activity of 9030612M13Rik, as it may rely on Src signaling for its activation. |